Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Kaan Certel Ph.D. | President, CEO & Director | -- | -- | -- |
| Dr. David A. Berry M.D., Ph.D. | Founder | 20.33k | -- | 1978 |
| Ms. Barbara Y. Chan CPA | Principal Financial Office, Principal Accounting Officer & Chief Accounting Officer | -- | -- | 1964 |
| Dr. Jennifer Nelson Ph.D. | Chief Scientific Officer | -- | -- | -- |
| Ms. Eva Stroynowski | Senior Vice President of Investor Relations & Corporate Affairs | -- | -- | -- |
| Mr. Anthony Mullin | Chief People Officer | -- | -- | -- |
| Mr. Charles O'Donnell Ph.D. | VP and Head of Computational Genomics & Data Sciences | -- | -- | -- |
| Dr. Joe Newman Ph.D. | Senior Vice President of Early Discovery | -- | -- | -- |
OMGAQ
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 93
Description
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. On February 10, 2025, Omega Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available